LI
PTCT icon

LMCG Investments’s PTC Therapeutics PTCT Stock Holding History

LMCG Investments’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$3.88M Buy
+145,222
New +$6.21M 0.08% 319
2015
Q1 		– Sell
-20,659
Closed -$1.07M – 555
2014
Q4 		$1.07M Buy
+20,659
New +$909K 0.02% 385

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

LMCG Investments's PTCT Position: Q3 2015 in Review

LMCG Investments opened a new position in PTC Therapeutics (PTCT) in Q3 2015: 145,222 shares worth $3.88M. The stake represents 0.08% of the portfolio and ranks #319 among its holdings. This is a return to the name: LMCG Investments previously reported a position in PTCT as recently as Q4 2014.

LMCG Investments first reported a position in PTCT in Q4 2014 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold PTCT as of Q3 2015.

  • LMCG Investments held 145,222 shares of PTC Therapeutics worth $3.88M as of Q3 2015.
  • PTC Therapeutics was a new LMCG Investments position in Q3 2015.
  • PTC Therapeutics made up 0.08% of LMCG Investments's portfolio in Q3 2015, its #319 holding.
  • LMCG Investments first reported a position in PTC Therapeutics in Q4 2014 and has held it in 2 quarters since.
  • 157 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.